PL1740213T3 - Ciekły preparat hormonu wzrostu - Google Patents

Ciekły preparat hormonu wzrostu

Info

Publication number
PL1740213T3
PL1740213T3 PL05774044T PL05774044T PL1740213T3 PL 1740213 T3 PL1740213 T3 PL 1740213T3 PL 05774044 T PL05774044 T PL 05774044T PL 05774044 T PL05774044 T PL 05774044T PL 1740213 T3 PL1740213 T3 PL 1740213T3
Authority
PL
Poland
Prior art keywords
growth hormone
metal salt
liquid growth
hormone formulation
alkaline earth
Prior art date
Application number
PL05774044T
Other languages
English (en)
Inventor
Tudor Arvinte
Kleiber Karine Luet
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of PL1740213T3 publication Critical patent/PL1740213T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
PL05774044T 2004-04-07 2005-03-30 Ciekły preparat hormonu wzrostu PL1740213T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04101444 2004-04-07
PCT/EP2005/051448 WO2005105148A2 (en) 2004-04-07 2005-03-30 Liquid growth hormone formulation
EP05774044A EP1740213B9 (en) 2004-04-07 2005-03-30 Liquid growth hormone formulation

Publications (1)

Publication Number Publication Date
PL1740213T3 true PL1740213T3 (pl) 2012-08-31

Family

ID=34928942

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05774044T PL1740213T3 (pl) 2004-04-07 2005-03-30 Ciekły preparat hormonu wzrostu

Country Status (24)

Country Link
US (1) US7662393B2 (pl)
EP (1) EP1740213B9 (pl)
JP (1) JP4991522B2 (pl)
KR (1) KR101120879B1 (pl)
CN (1) CN100574801C (pl)
AT (1) ATE547121T1 (pl)
AU (1) AU2005237775B2 (pl)
BR (1) BRPI0508798A (pl)
CA (1) CA2559918A1 (pl)
CY (1) CY1113834T1 (pl)
DK (1) DK1740213T3 (pl)
EA (1) EA010626B1 (pl)
ES (1) ES2383994T3 (pl)
HK (1) HK1098708A1 (pl)
HR (1) HRP20120235T1 (pl)
IL (1) IL178416A (pl)
MX (1) MXPA06011029A (pl)
NO (1) NO337249B1 (pl)
PL (1) PL1740213T3 (pl)
PT (1) PT1740213E (pl)
RS (1) RS52310B (pl)
SI (1) SI1740213T1 (pl)
UA (1) UA89781C2 (pl)
WO (1) WO2005105148A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1174457B1 (en) * 1999-12-03 2004-12-22 Toray Industries, Inc. Biaxially stretched polyester film for forming
EP2142207A4 (en) * 2007-04-04 2013-01-16 Theratechnologies Inc PHARMACEUTICAL FORMULATIONS OF GHRH MOLECULES
EP2525833A2 (en) 2010-01-22 2012-11-28 Novo Nordisk Health Care AG Stable growth hormone compounds
CN106139158A (zh) 2010-01-22 2016-11-23 诺沃—诺迪斯克保健股份有限公司 体内功效延长的生长激素
EP2417982A1 (en) * 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
US20140194356A1 (en) 2011-07-25 2014-07-10 Sandoz Ag Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein
US8871713B2 (en) * 2013-03-01 2014-10-28 Theratechnologies Inc. Formulations of growth hormone releasing factor (GRF) molecules with improved stability
US11045523B2 (en) 2013-04-05 2021-06-29 Novo Nordisk Healthcare Ag Formulation of growth hormone albumin-binder conjugate
EP3431508A4 (en) * 2016-03-14 2019-08-14 JCR Pharmaceuticals Co., Ltd. SERUM ALBUMIN-20-K-GROWTH HORMONE FUSION PROTEIN
US20200237652A1 (en) * 2017-08-08 2020-07-30 Csl Behring Ag Hemopexin formulations
WO2024026224A1 (en) 2022-07-29 2024-02-01 University Of Rochester Methods for improving muscle mass, strength, or function with a combination of testosterone and growth hormone

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3325223A1 (de) * 1983-07-13 1985-01-24 Hoechst Ag, 6230 Frankfurt Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung
JPS60123426A (ja) * 1983-12-07 1985-07-02 Eisai Co Ltd 経鼻投与用セクレチン製剤
DE3584560D1 (de) * 1984-04-09 1991-12-05 Du Pont Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
PT83095B (en) * 1985-07-30 1987-12-23 Int Minerals & Chem Corp Method for the stabilization of growth promoting hormones using polyoxyethylene-polyoxypropylene copolymers
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
ATE359824T1 (de) * 1992-07-31 2007-05-15 Genentech Inc Wässrige formulierung enthaltend menschliches wachstumshormon
JPH0892125A (ja) * 1994-09-21 1996-04-09 Nippon Chem Res Kk 水性医薬組成物
AUPN801296A0 (en) * 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
US20020077461A1 (en) * 1996-04-24 2002-06-20 Soren Bjorn Pharmaceutical formulation
US6759393B1 (en) * 1999-04-12 2004-07-06 Pfizer Inc. Growth hormone and growth hormone releasing hormone compositions
JP2003504346A (ja) * 1999-07-12 2003-02-04 グランデイス・バイオテツク・ゲー・エム・ベー・ハー 成長ホルモン製剤
EP1309312A2 (en) * 2000-08-07 2003-05-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
CA2466642C (en) * 2001-11-14 2011-01-18 Guohua Chen Injectable depot composition
AR040526A1 (es) * 2002-07-09 2005-04-13 Grandis Biotech Gmbh Formulaciuones de hgh en alta concentracion que contienen fenol
WO2004082707A2 (en) * 2003-03-18 2004-09-30 Ares Trading Sa Stabilisation of growth hormones in solution

Also Published As

Publication number Publication date
RS52310B (en) 2012-12-31
KR20070005628A (ko) 2007-01-10
NO337249B1 (no) 2016-02-22
EP1740213B1 (en) 2012-02-29
WO2005105148A3 (en) 2006-07-20
SI1740213T1 (sl) 2012-04-30
EP1740213B9 (en) 2012-06-13
UA89781C2 (uk) 2010-03-10
BRPI0508798A (pt) 2007-09-04
AU2005237775B2 (en) 2010-03-04
HK1098708A1 (en) 2007-07-27
WO2005105148A2 (en) 2005-11-10
KR101120879B1 (ko) 2012-02-27
WO2005105148A8 (en) 2005-12-08
IL178416A0 (en) 2007-02-11
EA200601874A1 (ru) 2007-02-27
JP4991522B2 (ja) 2012-08-01
ES2383994T3 (es) 2012-06-28
AU2005237775A1 (en) 2005-11-10
EA010626B1 (ru) 2008-10-30
IL178416A (en) 2012-12-31
CN100574801C (zh) 2009-12-30
US20080038292A1 (en) 2008-02-14
PT1740213E (pt) 2012-03-21
MXPA06011029A (es) 2007-01-25
NO20065097L (no) 2007-01-02
CA2559918A1 (en) 2005-11-10
DK1740213T3 (da) 2012-04-10
US7662393B2 (en) 2010-02-16
JP2007532515A (ja) 2007-11-15
EP1740213A2 (en) 2007-01-10
CN1946427A (zh) 2007-04-11
CY1113834T1 (el) 2016-07-27
ATE547121T1 (de) 2012-03-15
HRP20120235T1 (hr) 2012-04-30

Similar Documents

Publication Publication Date Title
HK1098708A1 (en) Liquid growth hormone formulation
EA015464B9 (ru) Гербицидные составы с улучшенной эффективностью
TW200735773A (en) Insecticidal compositions with improved activity
TW200735897A (en) HFSH aqueous formulation
WO2002062844A3 (en) Long lasting growth hormone releasing factor derivatives
WO2005117919A3 (en) Delayed-setting calcium phosphate pastes
TR200801337T1 (tr) Suda zayıf çözülebilen farmasötik ajanlar ve antimikrobiyal ajanlar içeren kompozisyonlar.
WO2008057802A3 (en) Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
CL2004000782A1 (es) Composicion farmaceutica parenteral que comprende (a) piperacilina, (b) tazobactamo, y un acido aminocarboxilico quelante, que ademas puede contener un tampon, como citrato, y opcionalmente un aminoglicosido; procedimientos para su preparacion; y uso
RS20070512A (en) Pharmaceutical sustained release compositionsand processes thereof
GEP20084340B (en) Pharmaceutical compositions comprising fentanyl for intranasal delivery
MY146947A (en) Antiparasitic agent for fish and method of controlling proliferation of fish parasites
WO2006076426A3 (en) Multi-purpose bio-material composition
MX2007013327A (es) Formulaciones de liberacion prolongada.
WO2008102349A3 (en) Terbinafine formulation for iontophoresis
WO2004082707A3 (en) Stabilisation of growth hormones in solution
CR20200242A (es) Formulaciones de composiciones de vacuna contra el virus del dengue
TW200744993A (en) Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
EP1767090A4 (en) CLATHRATE COMPOUND, METHOD FOR CONTROLLING THE CONCENTRATION OF AQUEOUS SOLUTION IN AN AGROCHEMICAL ACTIVE INGREDIENT, AND AGROCHEMICAL PREPARATION
MY157943A (en) Aqueous suspension concentrates
NZ624275A (en) Sustained-release preparation
MX2009011817A (es) Formulaciones de aminoacido n-halogenado que contienen acido alifatico.
TW200514553A (en) Therapeutic agent for hepatitis C
HK1052946A1 (en) Dry compositions containing hydrophobic amino acid
MX342473B (es) Sales de acido isetionico que contienen nitrogeno en mezclas de tanque y de rocio listas para utilizarse en campo.